";s:4:"text";s:20477:"Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen. TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27. Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference. Aromatase inhibitors for chemoprevention. If you are Dr. Goss and would like to add your Hospital Affiliations, please update your free profile at Doximity. He was raised in a company town called Alcoa, Tennessee. Kathrin Strasser-Weippl, Gautam Sudan, Ravi Ramjeesingh, Lois E. Shepherd, Joyce O'Shaughnessy, Wendy R. Parulekar, P Liedke, Bingshu E. Chen, Paul E. Goss. Add to wishlist. 3. Cool. West Valley View, Avondale, Arizona Friday, May 18, 2012 Paul D. Goss, 63, of Litchfield Park died May 13, 2012, at St. Joseph's Hospital in Phoenix. Goss PE, Barrios CH, Chan A, Chia SKL, Delaloge S, Ejlertsen B, Ingle JN, Moy B, Iwata H, Holmes FA, Mansi J, Von Minckwitz G, Han L, Thiele A, Agrapart V, Freyman A, Truscello J, Berkenblit A, Finkelstein D, A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women, Tessa Cigler, Harriet Richardson, Martin J. Yaffe, Carol J. Fabian, D. Johnston, JN Ingle, E. Nassif, R. L. Brunner, M. E. Wood, J. L. Pater, Haiqing Hu, Shangle Qi, Dongsheng Tu, Paul E. Goss, Aromatase immunoreactivity is increased in mammographically dense regions of the breast, Celine M. Vachon, Hironobu Sasano, Karthik Ghosh, Kathleen R. Brandt, David A. Watson, Carol Reynolds, Wilma L. Lingle, Paul E. Goss, Rong Li, Sarah E. Aiyar, Christopher G. Scott, V. Shane Pankratz, Richard J. Santen, James N. Ingle, Does tumour dormancy offer a therapeutic target, Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women, Andrea Z. LaCroix, Trevor J. Powles, C. Kent Osborne, Kevin Wolter, John R. Thompson, David D. Thompson, D. Craig Allred, Roisin Armstrong, Steve Cummings, Richard Eastell, Kristine E. Ensrud, Paul E. Goss, Lee Andrew George, Patrick Neven, David M. Reid, Madelyn Curto, Slobodan Vukicevic, Genome-wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors, James N. Ingle, Daniel J. Schaid, Paul E. Goss, Mohan Liu, Taisei Mushiroda, Judy Anne W. Chapman, Michiaki Kubo, Gregory D. Jenkins, Anthony Batzler, Lois E. Shepherd, Joseph L. Pater, Liewei Wang, Matthew J. Ellis, Vered Stearns, Daniel C. Rohrer, Matthew P. Goetz, Kathleen I. Pritchard, David A. Flockhart, Yusuke Nakamura, Richard M. Weinshilboum. Paul E. Goss, A K Stewart, Flix Couture, Richard Klasa, Stefan Glck, Leonard Kaizer, Ronald L. Burkes, Danielle Charpentier, Martin C. Palmer, L. M. Tye, Helene Dulude, Randomized Phase III Trial Comparing the New Potent and Selective Third-Generation Aromatase Inhibitor Vorozole With Megestrol Acetate in Postmenopausal Advanced Breast Cancer Patients, Paul E. Goss, Eric P. Winer, Ian F. Tannock, Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer, Thomas F. Hack, Lorenzo Cohen, Joel Katz, Lynda S. Robson, Paul E. Goss, Evolving perspectives in contralateral breast cancer, Laura A. Dawson, Edward Chow, Paul E. Goss, Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen, Ellen Warner, David W. Hedley, Irene L. Andrulis, RE Myers, Maureen E. Trudeau, David Warr, Kathleen I. Pritchard, Martin E. Blackstein, Paul E. Goss, Edmee Franssen, Kathie Roche, S Knight, S Webster, R A Fraser, S Oldfield, W Hill, R Kates. Liedke, Judy-Anne W. Chapman, Lois E. Shepherd, Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer, Kathrin Strasser-Weippl, Tanja Badovinac-Crnjevic, Lei Fan, Paul E. Goss, Yanin Chavarri-Guerra, Richard Sullivan, Paul E. Goss, Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker, Dennis C. Sgroi, Erin Carney, Elizabeth Zarrella, Lauren Steffel, Shemeica Binns, Dianne M. Finkelstein, Jackie Szymonifka, Atul K. Bhan, Lois E. Shepherd, Yi Zhang, Catherine A. Schnabel, Mark G. Erlander, James N. Ingle, Peggy L. Porter, Hyman B. Muss, Katherine I. Pritchard, Dongsheng Tu, David L. Rimm, Paul E. Goss. The Natural Way Booklet - Dr. Paul Goss-4508 West Slauson Ave. Los Angeles, CA 90043 Hours: Store: Monday - Saturday : 8am-10pm : Sunday 10am-9pm Restaurant : 8:30am-10pm : 10am-9pm The practitioner's primary taxonomy code is 207RH0003X with license number 220533 (MA). Dr. Goss discusses problems distributing his CKLS products on the market. Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Physician Investigator (Cl) Mass General Research Institute Professor of Medicine Harvard Medical School Research Staff Hematology-Oncology, Massachusetts General Hospital Education. Frances M. Boyle, Ian E. Smith, Joyce O'Shaughnessy, Bent Ejlertsen, Aman U. Buzdar, Pierre Fumoleau, William J. Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I. Pritchard, Deborah Lindquist, Mayur M. Amonkar, Yingjie Huang, E. Rappold, L. S. Williams, Jing Wang-Silvanto, Tomomi Kaneko, Dianne M. Finkelstein, Paul E. Goss, Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial, Vered Stearns, Judith-Anne W. Chapman, Cynthia X. Ma, Matthew J. Ellis, James N. Ingle, Kathleen I. Pritchard, G. Thomas Budd, Manuela Rabaglio, George W. Sledge, Aurlie Le Matre, Jessica Kundapur, Pedro E.R. Paul E. Goss, Lynn Schwertfeger, Martin E. Blackstein, Neill A. Iscoe, Robert J. Ginsberg, William J. Simpson, Donald P. Jones, Frances A. Shepherd, A Phase I Study of Swainsonine in Patients with Advanced Malignancies, Paul E. Goss, Jose Baptiste, Berny Fernandes, Michael Baker, James W. Dennis. Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus. Loving longtime partner of 29 years to Wanda Ceresia; loving father of Tony (Brenda) Goss, Angela (Gil) Grooms, and Douglas Goss; dear grandfather of Anthony, Brendan, Isabella Goss; Geddy (Cyd) Cary-Avery, Bowie Avery, and Trinity Avery; and Luke Goss; dear brother of Sylvia (Gene) Stamm, Joseph Granville (Linda) Goss, Warren (Mae) Goss, Dean (Susan . Mark Clemons, Sarah Danson, T Hamilton, Paul E. Goss, Aromatase inhibitors in the treatment and prevention of breast cancer. Luk C, Goss P, Pritchard K, Whelan TJ, Liu S, Shepherd L, Pater J. About DR. PAUL EDWARD GOSS MBBCH. under the supervision of Dr. Michael Crump and Dr. Paul Goss, investigating high dose chemotherapy strategies to treat high risk adjuvant and metastatic disease patients. He is affiliated with medical facilities such as Lehigh Valley Hospital - Cedar Crest and Penn . Robert NJ, Goss PE, Ingle JN, Tu D, Shepherd L, Palmer M, Pater J. Become a New Body distributor and Herbal Consultant: CLICK HERE I'm happy to give you . 2. Stopping trials for benefit can (sometimes) benefit patients. Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer, Nadine Tchen, Helen G. Juffs, Fiona P. Downie, Qi-long Yi, Hanxian Hu, Irene Chemerynsky, Mark Clemons, Michael Crump, Paul E. Goss, David Warr, Mary E. Tweedale, Ian F. Tannock. Website. Marcela G. del Carmen, Elkan F. Halpern, Daniel B. Kopans, Beverly Moy, Richard H. Moore, Paul E. Goss, Kevin S. Hughes. Dr. Goss graduated from the University of The Witwatersrand Faculty of Health Sciences in 1978. It gives you a detailed description of each herb and what each herb is good for based off your health issues. J. The Wall Street Journal interviews Paul Gross, M.D., about the growing emphasis medical schools are placing on humanities, including courses in writing and literature, in order to help produce physicians better able to provide sensitive personal care. Massachusetts General Hospital. DR. PAUL GOSS. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. An intracardiac mass presenting as atrial fibrillation in a patient with testicular carcinoma. Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter? I had a serious eye problem years ago and Dr Paul Goss cleared it up for me! There are helpful hints in the back of the booklet that are alphabetical by concern. Aromatase inhibitors and their potential clinical significance. Avon and the Avon Breast Cancer Crusade mark 25 year legacy of raising breast cancer awareness. Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer. Dr David Goss is an orthopaedic spine surgeon in Chesapeake and Suffolk, VA. Dr Goss has been extensively trained in a vast array of surgical and non-surgical techniques, to treat all spinal disorders and injuries. Jing Xu, Tanya Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss, Beow Y. Yeap, Bruce A. Chabner, Steven J. Isakoff. Moy B, Rappold E, Williams L, Kelly T, Nicolodi L, Maltzman JD, Goss PE. Your Price: $1.00. He is from . Improving access to high-cost cancer drugs in Latin America: Much to be done. Ingle J, Tu D, Shepherd L, Palmer M, Pater J, Goss P. Updated analysis of NCIC CTG MA.17 (letrozole vs. placebo to letrozole vs placebo) post unblinding. Robertson, Joseph A. Sparano, Andrew Tutt, Giuseppe Viale, Nicholas Wilcken, Norman Wolmark, Wiliam Wood, Milvia Zambetti, Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score, Piiha Lotta Jerevall, Jane E. Brock, Juan P. Palazzo, Tad J. Wieczorek, Michael Misialek, Anthony J. Guidi, Yun Wu, Mark G. Erlander, Yi Zhang, Catherine A. Schnabel, Paul E. Goss, Nora Horick, Dennis C. Sgroi. With a Table of Contents and an Index. a ch: 270B Bch ng, Phng 24, Qun Bnh Thnh, Thnh Ph H Ch Minh. Richard J. Santen, Lawrence M. Demers, Susan Ohorodnik, James Settlage, Peter Langecker, Dennis G Blanchett, Paul E. Goss, Shuping Wang, The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model, Paul E. Goss, Shangle Qi, Haiqing Hu, Angela M. Cheung, The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial, Harriet Richardson, D. Johnston, J. L. Pater, Paul E. Goss, Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17, Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Joseph L. Pater, Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen, Christopher M. Booth, Joseph L. Pater, Paul E. Goss. Also known as P W Goss, Paul Kevin Mcmanus. Dr. Goss New Body Products CAN (Fluoride of Lime) $ 26.00. Letrozole for the management of breast cancer. Risks versus benefits in the clinical application of aromatase inhibitors. Paul E. Goss, Ronald Burkes, Rudinskas L, King M, Chow W, Myers R, Davidson M, Poldre P, Michael Crump, D M Sutton, Dice (Dexamethasone, Ifosfamide, Cisplatin, Etoposide) as Salvage Therapy in Non-Hodgkin's Lymphomas, Paul E. Goss, Frances A. Shepherd, J G Scott, Michael Baker, D M Sutton, S B Sutcliffe. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report. Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis. Is there ever a role for salvage operations in limited small-cell lung cancer? Extended adjuvant endocrine therapy in breast cancer: current status and future directions. Todd, Timothy Winton, M. Rubinger, Else Johansen, A K Stewart, Frances A. Shepherd, Paul E. Goss, Ellen Warner, Denis Bailey, Michael Baker, Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: Preliminary report of a phase II study, Paul E. Goss, Frances A. Shepherd, Scott Jg, Ellen Warner, Michael Baker, D M Sutton, H A Farquharson, Buick S, S. Sutcliffe. Rutgers, Cornelis J.H. Mohan Liu, Paul E. Goss, James N. Ingle, Michiaki Kubo, Yoichi Furukawa, Anthony Batzler, Gregory D. Jenkins, Erin E. Carlson, Yusuke Nakamura, Daniel J. Schaid, Judy Anne W. Chapman, Lois E. Shepherd, Matthew J. Ellis, Sundeep Khosla, Liewei Wang, Richard M. Weinshilboum, Prospective Validation of HLA-DRB1*07:01 Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury, Daniel J. Schaid, Colin F. Spraggs, Shannon K. McDonnell, Laura R. Parham, Charles J. Cox, Bent Ejlertsen, Dianne M. Finkelstein, E. Rappold, Joan Curran, Lon R. Cardon, Paul E. Goss, Lei Fan, Kathrin Strasser-Weippl, Junjie Li, Jessica St. Louis, Dianne M. Finkelstein, Ke Da Yu, Wan Qing Chen, Zhi Ming Shao, Paul E. Goss, Quality of life in MAP.3 (Mammary Prevention 3): A randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer, Elizabeth Maunsell, Paul E. Goss, Rowan T. Chlebowski, James N. Ingle, Jos E. Als-Martnez, Gloria E. Sarto, Carol J. Fabian, Pascal Pujol, Amparao Ruiz, Andrew Cooke, Susan L. Hendrix, Debra W. Thayer, Kendrith M. Rowland, Pierre Dub, Silvana Spadafora, Sandhya Pruthi, Lavina Lickley, Susan Ellard, Angela M. Cheung, Jean Wactawski-Wende, Karen A. Gelmon, D. Johnston, Andrea Hiltz, Michael Brundage, Joseph L. Pater, Dongsheng Tu, Harriet Richardson, Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer, Beverly Moy, Patrick Neven, Fabienne Lebrun, Meritxell Bellet, Binghe Xu, Tomasz Sarosiek, Louis Chow, Paul E. Goss, Charles Zacharchuk, Eric Leip, Kathleen Turnbull, Nathalie Bardy-Bouxin, Ladan Duvillie, Istvn Lng, Challenges to effective cancer control in China, India, and Russia, Paul E. Goss, Kathrin Strasser-Weippl, Brittany L. Lee-Bychkovsky, Lei Fan, Junjie Li, Yanin Chavarri-Guerra, Pedro E.R. A. Baptista, Paul E. Goss, Mai Nghiem, J. J. Krepinsky, Michael Baker, James W. Dennis. Tag Archives: Dr. Paul Goss. Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. Goss grew up in the small rural community of Alcoa, Tennessee. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE). Lorenzo Cohen, Thomas F. Hack, Carl de Moor, Joel Katz, Paul E. Goss. Familial testicular cancer in five members of a cancer-prone kindred. Young Women With Breast Cancer in Mexico: Results of the Pilot Phase of the Joven & Fuerte Prospective Cohort. NCIC CTG MA.17: Intent to treat analysis (ITT) of randomized patients after a median follow-up of 54 months. . Key Principal: Paul Goss See more contacts Industry: Spices and herbs. "These drugs have been shown to prevent the occurrence of invasive and pre-invasive breast cancers," says Dr. Paul Goss, director of breast cancer research at the Massachusetts General . Did cultural apprenticeship with Baaba Heru at the Shrine of Ptah; does independent research & self-study. Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27. Liedke, C S Pramesh, Tanja Badovinac-Crnjevic, Yuri Sheikine, Zhu Chen, You-Lin Qiao, Z Shao, Yi-Long Wu, Daiming Fan, Louis W.C. Chow, Jun Wang, Qiong Zhang, Shiying Yu, Gordon C Shen, Jie He, Arnie Purushotham, Richard Sullivan, Rajendra A. Badwe, Shripad Banavali, Reena Nair, Lalit Kumar, Purvish M. Parikh, Somasundarum Subramanian, Pankaj Chaturvedi, Subramania Iyer, Surendra S Shastri, Raghunadhrao Digumarti, Enrique Soto-Perez-de-Celis, Dauren Adilbay, Vladimir Semiglazov, Sergey Orlov, Dilyara Kaidarova, Ilya Tsimafeyeu, Sergei Tatishchev, Kirill D. Danishevskiy, Marc Hurlbert, Caroline Vail, Jessica St. Louis, A. Chan, Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial, Paul E. Goss, Dawn L. Hershman, Angela M. Cheung, James N. Ingle, Sundeep Khosla, Vered Stearns, Haji Chalchal, Kendrith M. Rowland, Hyman B. Muss, Hannah M. Linden, Judite Scher, Kathleen I. Pritchard, C. Elliott, Tanja Badovinac-Crnjevic, Jessica St. Louis, Judith Anne W. Chapman, Lois E. Shepherd. A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients. Pritzker. DNA damage and repair in human cells exposed to sunlight. Bu Cc Trung tm qun Bnh Thnh thnh ph H Ch Minh. Cigler T, Higgins MJ, Szymonifka J, Partridge AH, Ligibel JA, Finkelstein D, Come SE, Ryan PD, Goss PE. Stearns V, Chapman JW, Ma CX, Ellis MJ, Ingle JN, Pritchard KI, Budd GT, Rabaglio M, Sledge GW, Le Maitre A, Kundapur J, Shepherd LE, Goss PE. Directions. Sgroi D, Hameed O, Hattab E, Chang B, Moulis S, Steffel L, Salunga R, Ma X, Erlander M, Goss P, Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17, James N. Ingle, Dongsheng Tu, Joseph L. Pater, Hyman B. Muss, Silvana Martino, Nicholas J. Robert, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Paul E. Goss, A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer, Xiao-Jun Ma, Ranelle C. Salunga, Sonika Dahiya, Wilson Wang, Erin Carney, Virginie Durbecq, Adrian L. Harris, Paul E. Goss, Christos Sotiriou, Mark G. Erlander, Dennis C. Sgroi, Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis, Scott D. Solomon, Janet Wittes, Peter V. Finn, Robert A. Fowler, Jaye L. Viner, Monica M. Bertagnolli, Nadir Arber, Bernard Levin, Curtis L. Meinert, Barbara K. Martin, Joseph L. Pater, Paul E. Goss, Peter Lance, Stefanie Obara, Emily Y. Chew, Jonghyeon Kim, Gretchen Arndt, Ernest T. Hawk, Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen, Paul E. Goss, James N. Ingle, Joseph L. Pater, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Dongsheng Tu, Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17, Hyman B. Muss, Dongsheng Tu, James N. Ingle, Silvana Martino, Nicholas J. Robert, Joseph L. Pater, Timothy J. Whelan, Michael Palmer, Martine Piccart, Lois E. Shepherd, Kathleen I. Pritchard, Zhi He, Paul E. Goss. ";s:7:"keyword";s:12:"dr paul goss";s:5:"links";s:783:"Estate Agents Jedburgh Scottish Borders,
Dan Hamilton Singer Cause Of Death,
Pennsylvania State Police Fire Marshal,
Evan Funke Wife,
Alternative Titles For Chief Administrative Officer,
Articles D
";s:7:"expired";i:-1;}